戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 iate-negative urine specimens (thrice weekly urinalysis).
2 ch illicit opioid use was measured by weekly urinalysis.
3 ) admissions, with 584438 (13%) including >1 urinalysis.
4 uped according to symptoms, bacteriuria, and urinalysis.
5 r lung disease was assessed by histology and urinalysis.
6 d chemistry, complete blood count (CBC), and urinalysis.
7       All volunteers had negative results of urinalysis.
8 treptococcal tests, and improved methods for urinalysis.
9 (65%), prostate-specific antigen test (65%), urinalysis (40%), blood glucose measurement (41%), fecal
10             Finally, the use of an augmented urinalysis and a discussion of imaging for first febrile
11 tion (including digital rectal examination), urinalysis and bladder diary as being essential in the a
12  no alternative diagnosis) UTI on pretherapy urinalysis and culture.
13 re 2,247 nondiabetics and 537 diabetics with urinalysis and follow-up data available (proteinuria n =
14        Renal disease was assessed by regular urinalysis and histologic evaluation.
15                                              Urinalysis and rheumatoid factor (RF) tests were conduct
16 ustrated by applying it to data collected by urinalysis and self-report in 1992-1993 in a national mu
17 ance with the CM groups as indicated by both urinalysis and self-reported cocaine use data.
18 ety and efficacy were assessed on retention, urinalysis and self-reported drug use, symptoms, and pat
19 ectal exam should be performed, as well as a urinalysis and serum creatinine.
20 eteral obstruction underwent contemporaneous urinalysis and unenhanced CT.
21 n model was used to examine the incidence of urinalysis and urine culture testing for select diagnose
22 on with possible laboratory assessment using urinalysis and urine culture.
23 logic analysis, analysis of blood chemistry, urinalysis, and electrocardiographic parameters; these m
24 actate dehydrogenase, proteinuria on routine urinalysis, and hypertension were the earliest markers o
25                   Complete blood cell count, urinalysis, and viral studies were obtained weekly.
26 ion (N-telopeptide of collagen cross-links); urinalysis; and phosphate, calcium, and creatinine level
27 al examination, hematology, serum chemistry, urinalysis, antibody titers, and radiographic evaluation
28 y taking, physical examination, and dipstick urinalysis are not able to reliably lower the posttest p
29 uria (ie, any number of white blood cells on urinalysis) assessed every 2 months over the 1-year stud
30 pients remain with normal renal function and urinalysis at 3 years after the transplant.
31 erve as a low-cost, point-of-care, sensitive urinalysis biosensor to monitor UTI and gonorrhea from h
32 tion must be undertaken, including screening urinalysis, blood chemistries, and renal sonography.
33 ADCs) on MRI were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and bio
34 panel, routine haematology, blood chemistry, urinalysis, coagulation, and complement variables.
35                                          The urinalysis combined with the history and physical examin
36 ere referred to a hospital laboratory for an urinalysis, complete blood count, and a standard blood c
37 n that includes motivational interviewing, a urinalysis contingency, and social skills training.
38 ere retrospectively compared with results of urinalysis, cystoscopy and/or ureteroscopy, and/or surge
39                              Self-report and urinalysis data are consistent with a greater than 90% r
40 res used included self-report of relapse and urinalysis drug and alcohol screenings.
41 gative specimens for street heroin on weekly urinalysis during weeks 14-26.
42 gs of hematologic analysis, blood chemistry, urinalysis, electrocardiography, or physical examination
43 DVICE 2: Clinicians should not use screening urinalysis for cancer detection in asymptomatic adults.
44 creatinine (glomerular defects), microscopic urinalysis for hematuria (hemorrhagic cystitis, bladder
45  counts (therapy-related leukemia), dipstick urinalysis for proteinuria and serum blood urea nitrogen
46 strate that bioplasmonic paper enables rapid urinalysis for the detection of kidney cancer biomarkers
47               Serum chemistries, hematology, urinalysis, gastrointestinal complications, liver and re
48 m cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum creatinine level.
49                                  Microscopic urinalysis, high-performance liquid chromatography (HPLC
50 n in water, and resazurin assay in milk) and urinalysis (i.e., nitrite, urobilinogen, and pH assays i
51            Comprehensive blood chemistry and urinalysis indicate that Hpse2 mutants have renal dysfun
52 ortant factors, such as specimen collection, urinalysis interpretation, culture thresholds, and antim
53                                            A urinalysis is now clear without traces of inflammation,
54 ility of using these MIPs as part of a total urinalysis MIP system.
55 le it was suggested utilizing the "enhanced" urinalysis, not as a replacement to culture but as a pot
56 tudy intended to evaluate bacteriuria in the urinalysis of patients with C1-INH-HAE.
57 of the 3D paper-based microfluidic system, a urinalysis of protein and glucose assays is conducted.
58                                     A normal urinalysis on day 7 had a 97% (confidence interval 90 to
59 clinical chemistry, hematology, coagulation, urinalysis, orthostatic vital signs, WSF, or 12-lead ECG
60 cardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum
61 ical chemistry, hematology, coagulation, and urinalysis; psychomotor functioning (using the Wayne Sac
62                                              Urinalysis results during the 16-week treatment period s
63  for retail items contingent on cocaine-free urinalysis results during treatment weeks 1 to 12.
64 ior in-treatment urinalysis results, whereas urinalysis results from participants in the CBT group we
65 come Measure The primary outcome measure was urinalysis results from twice-weekly treatment sessions.
66 respectively (high dose vs low dose, P<.05); urinalysis results were similarly dose related.
67 0 had normal serum creatinine levels, normal urinalysis results, and normal quantitative proteinuria.
68 g CM had significantly superior in-treatment urinalysis results, whereas urinalysis results from part
69               Digital rectal examination and urinalysis should be performed.
70                                     However, urinalysis showed increased albumin excretion by 4 weeks
71  signals of concern from laboratory blood or urinalysis tests.
72 results of dipstick testing with microscopic urinalysis that demonstrates 3 or more erythrocytes per
73  the utility of urine Gram stain relative to urinalysis (UA) is unclear.
74 se both are associated with abnormalities on urinalysis (UA).
75                   The routine performance of urinalysis, urine culture, or both during subsequent feb
76      BUN, serum creatinine concentration and urinalysis were normal in all subjects.
77                                  Charges for urinalysis were present for 2086697 (47%) admissions, wi
78 f the uterus and ovaries (ages 30-35 years); urinalysis with cytology (ages 25-35 years); history, ex

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。